Dr. Kumaravel. J

Dr. Kumaravel. J

Assistant Professor
Department : Pharmacology

Introduction:

I am Dr. Kumaravel. J Joining as Assistant Professor in Pharmacology.

Educational Qualifications:

Degree Year Name of College & University Registration number with
date of registration
Name of State Medical council
MBBS 2016 Vinayaka Missions's Medical College, Karaikal. 122936 (17.04.2017) Tamilnadu Medical Council
MD 2021 Postgraduate Institute of Medical Education and Research, Chandigarh 122936 Delhi Medical Council
DNB 2021 National Board of Examinations 122936 Delhi Medical Council
DM 2024 Postgraduate Institute of Medical Education and Research, Chandigarh 122936 Delhi Medical Council

Details of Teaching experience till date:

Designation Department Institution From To Total
Junior Resident Pharmacology Postgraduate Institute of Medical Education and Research, Chandigarh 14.01.2019 31.12.2021 3 Years
Senior Resident Pharmacology Postgraduate Institute of Medical Education and Research, Chandigarh 01.01.2022 31.12.2024 3 Years
Assistant Professor Pharmacology SRM Medical College Hospital and Research Centre 02.05.2025 Till Date
Research & Publications :
  • 1. Mahendru D, Kumaravel. J, Mahalmani VM, Medhi B. Athlete Biological Passport: Need and Challenges. Indian Journal of Orthopaedics. 2020 Jan 31:1-7 PMID: 32399144 PMCID: PMC7205923 DOI: 10.1007/s43465-020-00040-7 2. Singh A, Kumaravel J, Mahendru D, Yadav M, Kumar H, Prakash A, Medhi B. Hydroxychloroquine drug safety review for the prophylaxis of SARS COV 2 Pandemic. International Journal of Pharmaceutical Sciences and Research.2020. Received: 05 May 2020 Revised: 22 July 2020 Accepted: 27 July 2020 DOI: 10.13040/IJPSR.0975-8232.11(8).3535-43 Published: 01 August 2020 . 3. Kumaravel J, Mahendru D, Mahamnai VM, et al. Athlete Biological Passport: Practical Application in Sports. J Postgrad Med Edu Res 2020. Volume 54 | Issue 4 | Year 2020.
  • 4. Mahalmani V, Kumaravel J, Jain M, Prakash A, Medhi B. Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak. Indian Journal of Pharmacology.2021 May 1;53 (3):187.PMCID: PMC8262419 PMID: 34169902. 5. Kumaravel J, Sowmini, Avti P, Medhi B. Marathon mice: researcher view on potential roles in preclinical research. Indian Journal of Pharmacology. 2021 Mar1;53 (2):99. PMID: 34100392 PMCID: PMC8265421 DOI: 10.4103/ijp.ijp_324_21 6. Patil AN, Kumar MP, Yadav R, Kosey S, Behl T, Kumaravel J. Drug information services in low-resource setting: a responsibility of pharmacists or pharmacologists or both the professions conjointly. Journal of Pharmacy and Bioallied Sciences.2021 Apr 1;13(2):283 PMCID: PMC8291111 PMID: 34349491 J Pharm Bioallied Sci . 2021 May 26;13(2):283–290. doi: 10.4103/jpbs.JPBS_748_20
  • 7. Mahendru D, Vidya M. Mahalmani, Kumaravel J, Gitika Batra, Prakash A, Medhi B. Recent advances in treatment of myasthenia gravis. Drug Bulletin 2020; 45: 8-15. 8. Kumaravel, Ajay P, Bikash M. Stem Cell Research: Current Update On Efficiacy and Safety. Drug Bulletin 2019;44 (1): 1-6. 9. Arjun Singh, Mukesh Yadav, Kumaravel J et al E-Prescription (Cpoe) In Indian Hospitals: A Strategy to Prevent Prescription Errors Drug Bulletin - Volume 45, Issue 3, July 2020. 10. Smita P, Narayan PA, J Kumaravel, Gaurav P. Therapeutic drug monitoring for cytotoxic anticancer drugs: Principles and evidence-based practices. Front Oncol.2022 Dec 8;12:1015200.
  • 11. Gupta S, Kumaravel J, Prakash A, Medhi B. Concept of essential medicines and recent updates. Indian J Pharmacol. 2023 Jan-Feb;55(1):1-5. 12. Book Chapter: Kumaravel J, sowmini K, Ajay Prakash, Bikash Medhi Ethical, legal and social issues in Therapeutic implications of Pharmacogenomics in clinical scenario 2023. 13. Kumaravel J, Singh H, Kaur S, Prakash A, Medhi B. Peptides and peptidomimetics as a therapeutic candiadate for the treatment of COVI-19: A brief review. Indian J Pharmacol.2023 Jan-Feb;55(1):53-58. 14. Choudhary G, Prajapat M, Kumaravel J, Prabha PK, Sarma P, Handa V, Kaur H, Patel AP, Medhi B. Update on omicron variant: What we know so far. Indian J Pharmacol.2022 Jan-Feb;54 (1):41-45.
  • 15. Kumar A, Hegde N, Kumaravel J, Mohindra R, Soni RK, Rathod R, Kumar M, Muthu V, Gamad N, Patil AN, Sharma PL. Comparison of master two-step exercise stress test versus six-min walk test in patients tested positive for SARS-CoV-2. J Family Med Prim Care. 2022 Nov;11(11):7008-7014. 16. Bikash Medhi, J Kumaravel, Prabha PK, Ajay Prakash. Nanomaterials and their Immunological Perspectives, Scopus Indexed (Internet). 2022 Dc.12(cited 2024 May 6);15(6):6191-5. 17. Kumaravel J, Sarma P, Suri V, Singh P, Prakash A, Medhi B. Therapeutic Drug Monitoring of Levetiracetam in Different Trimesters of Pregnant Women with Epilepsy in a Tertiary Care Center: A Prospective Study. Neurol India.2024 Mar 1;72(2):358-363.
Awards & Acheivements :
  • Best Poster Award: "Immunotherapeutics in Covid-19: Vaccine Update and Challenges" at National Level Workshop on 8th December 2020 (Pharmoscon-2020) Osmania Medical College Hyderabad. Best Paper Presentation Award: "Development and Validation of a HPLC Method for Quantification of Levetiracetam in Human Plasma and its Application in TDM Analysis" at National Level Workshop ASPIRE-2021 SRIHER Chennai.
  • Best Paper Oral Presentation Award 2nd Place: "Evaluation of Pharmacokinetic Profile of levetiracetam in different Trimesters of Pregnancy, Correlation With Clinical Outcome by Therapeutic Drug Monitoring: A Prospective Study" at National Level NWCPT 2021 PGIMER, Chandigarh. First Prize in Quize: 4th National Conference of SASPI-ASPICON 2022-AIIMS
  • First Prize in Quize: 4th National Evidence Based Medicine and Clinical research Conference 2023- EBCCON 2023, SRM Chennai.